The AbbVie Inc. line shows up 137 times in the congressional disclosure record between 2014 and 2026, filed by 48 members: 79 purchases against 58 sales. On balance the chamber has been net buyers, and the purchases sit up 40.4% against the latest close.
*Purchases only, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings report a range, never a share count, so this follows the stock rather than anyone's position size.
Members ranked by how their reported ABBV purchases have moved since, over roughly the last three years, weighted by disclosed band midpoint and marked to the latest close.
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2018-02-22 | Debbie Dingell | BUY | $1K–$15K | $117.56 | $256.46 2026-09-04 | +118.2% |
| 2018-01-02 | Rohit Khanna | SELL | $1K–$15K | $98.41 | $256.46 2026-09-04 | -160.6% exit |
| 2017-12-08 | Mike Kelly | BUY | $1K–$15K | $95.95 | $256.46 2026-09-04 | +167.3% |
| 2017-11-30 | Rohit Khanna | BUY | $15K–$50K | $96.92 | $256.46 2026-09-04 | +164.6% |
| 2017-11-07 | Kenneth R. Buck | SELL | $1K–$15K | $93.96 | $256.46 2026-09-04 | -172.9% exit |
| 2017-07-05 | Rohit Khanna | BUY | $1K–$15K | $72.48 | $256.46 2026-09-04 | +253.8% |
| 2017-01-20 | John Hoeven | SELL | $100K–$250K | $61.15 | $256.46 2026-09-04 | -319.4% exit |
| 2016-12-16 | Katherine M. Clark | SELL | $15K–$50K | $62.22 | $256.46 2026-09-04 | -312.2% exit |
| 2016-11-23 | Kenny Marchant | BUY | $1K–$15K | $60.18 | $256.46 2026-09-04 | +326.1% |
| 2016-09-06 | F. James Sensenbrenner Jr. | SELL | $1K–$15K | $64.61 | $286.74 2026-10-26 | -343.8% exit |
| 2016-06-22 | Debbie Dingell | BUY | $1K–$15K | $60.39 | $256.46 2026-09-04 | +324.7% |
| 2016-04-01 | Kenny Marchant | BUY | $1K–$15K | $57.42 | $256.46 2026-09-04 | +346.6% |
| 2016-03-03 | E. Scott Rigell | BUY | $15K–$50K | $55.93 | $256.46 2026-09-04 | +358.5% |
| 2016-01-07 | David A Perdue , Jr | BUY | $1K–$15K | $57.21 | $256.46 2026-09-04 | +348.3% |
| 2016-01-06 | F. James Sensenbrenner Jr. | SELL | $1K–$15K | $57.38 | $256.46 2026-09-04 | -346.9% exit |
| 2015-10-29 | Kenny Marchant | BUY | $1K–$15K | $54.10 | $286.74 2026-10-26 | +430.0% |
| 2015-09-15 | Robert J. Wittman | BUY | $1K–$15K | $59.20 | $286.74 2026-10-26 | +384.4% |
| 2015-09-10 | Gary C Peters | BUY | $1K–$15K | $59.58 | $286.74 2026-10-26 | +381.3% |
| 2015-08-31 | Kenny Marchant | SELL | $1K–$15K | $62.41 | $286.74 2026-10-26 | -359.4% exit |
| 2015-08-25 | Kenny Marchant | BUY | $1K–$15K | $60.71 | $286.74 2026-10-26 | +372.3% |
| 2015-07-01 | Kenny Marchant | BUY | $1K–$15K | $68.51 | $286.74 2026-10-26 | +318.5% |
| 2015-06-08 | K. Michael Conaway | BUY | $1K–$15K | $67.79 | $286.74 2026-10-26 | +323.0% |
| 2015-05-11 | Kenny Marchant | BUY | $1K–$15K | $65.20 | $286.74 2026-10-26 | +339.8% |
| 2015-05-01 | Kenny Marchant | BUY | $1K–$15K | $64.32 | $286.74 2026-10-26 | +345.8% |
| 2015-04-06 | F. James Sensenbrenner Jr. | SELL | $1K–$15K | $57.61 | $286.74 2026-10-26 | -397.7% exit |
| 2015-04-02 | Dan Benishek | BUY | $1K–$15K | $57.01 | $286.74 2026-10-26 | +403.0% |
| 2015-03-11 | John A. Boehner | BUY | $15K–$50K | $56.62 | $286.74 2026-10-26 | +406.4% |
| 2015-03-10 | Sheldon Whitehouse | SELL | $1K–$15K | $55.84 | $286.74 2026-10-26 | -413.5% exit |
| 2015-02-25 | John Hoeven | BUY | $100K–$250K | $60.62 | $286.74 2026-10-26 | +373.0% |
| 2015-02-12 | Thomas R Carper | BUY | $1K–$15K | $57.05 | $286.74 2026-10-26 | +402.6% |
| 2015-02-03 | James B. Renacci | BUY | $1K–$15K | $61.65 | $286.74 2026-10-26 | +365.1% |
| 2015-01-30 | James B. Renacci | BUY | $1K–$15K | $60.35 | $286.74 2026-10-26 | +375.1% |
| 2014-12-18 | Sheldon Whitehouse | BUY | $1K–$15K | $67.92 | $286.74 2026-10-26 | +322.2% |
| 2014-12-16 | Bill Flores | SELL | $50K–$100K | $65.25 | $286.74 2026-10-26 | -339.4% exit |
| 2014-09-29 | John Hoeven | SELL | $100K–$250K | $58.52 | $286.74 2026-10-26 | -390.0% exit |
| 2014-04-28 | John Hoeven | BUY | $50K–$100K | $50.87 | $286.74 2026-10-26 | +463.7% |
| 2014-03-31 | John Hoeven | BUY | $50K–$100K | $51.40 | $286.74 2026-10-26 | +457.9% |
Buys are marked to the latest close and treated as open. A sell tagged rt closes an earlier disclosed buy in the same name. exit shows how the stock moved after the member sold.
48 members of the U.S. House and Senate have disclosed AbbVie Inc. transactions under the STOCK Act — 79 purchases and 58 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a ABBV purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed ABBV buys are up 40.4% versus the latest close of $286.74. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded ABBV and how it performed.